NGF and depressive symptom measurement: Relevant models of neurological pathologies where IND-NGF efficacy has been attempted include cerebral ischemia, AD, traumatic brain and spinal cord injuries, epilepsy, amyotrophic lateral sclerosis, hypogonadism related to premature aging, and depression.